Newsletter
October 2021

 
 

Welcome to our October newsletter which features all the latest news and events from the neuromuscular community.


Articles in the edition...

  • TREAT-NMD Welcomes new CEO
  • TREAT-NMD Statement on Stem Cell Tourism
  • TREAT-NMD Advisory Committee for Therapeutics (TACT) hosts 25th meeting and will be in person again in 2022!
 
 
 
‌
Uncategorized Business Card 5128935

TREAT-NMD Welcomes New CEO

We are pleased to announce that we have appointed David Allison as the new CEO of TREAT-NMD services Ltd (the not for profit legal entity established to manage the financial, operational and legal aspects of TREAT-NMD) who will be working closely with Jim Dowling, the TREAT-NMD executive chair...


 
Read More
‌
‌
Uncategorized Logo

TREAT-NMD Statement on Stem Cell Tourism

It has come to the attention of TREAT-NMD that families of patients with Duchenne muscular dystrophy are raising money to fund a ‘lifesaving’ stem cell treatments. The TREAT-NMD executive committee would like to issue the following statement...

 
Read More
‌
‌
Uncategorized Vancouver

7th TREAT-NMD International Conference 2022

There’s exciting news around the programme for the TREAT-NMD Conference, 15th-17th June 2022, Vancouver Canada...

 
Read More
‌
‌
Uncategorized TACT Zoom Oct 2021

TREAT-NMD Advisory Committee for Therapeutics (TACT) Hosts 25th Meeting and will be in person again in 2022!

The TREAT-NMD Advisory Committee for Therapeutics held its 25th meeting (virtually) on the 23rd of October. The Autumn meeting considered advice on pre-clinical work for Duchenne muscular dystrophy (DMD). We were delighted to welcome the application from Professor Guglielmo Sorci from the University of Perugia in Italy...

 
Read More
‌
‌
Uncategorized Korean Guide

Korean Translation of the Duchenne Muscular Dystrophy Guide for Families is now available!

We are delighted to announce that the DMD Guide for Families is now available in Korean. The guide is based on the 2018 Standards of Care for Duchenne Muscular Dystrophy (DMD); it provides valuable information to families and patients about aspects of care and treatment...

 
Read More
‌
‌
Uncategorized Nathalie Goemans

Retirement symposium - Nathalie Goemans

TREAT-NMD executive committee member Nathalie Goemans retired in 2020. Due to the pandemic her retirement symposium and formalities were postponed to October 15 2021...

 
Read More
‌
‌
Uncategorized Masterclass

TREAT-NMD Expert Masterclasses

Our Masterclasses are a fantastic opportunity to share current best practice with experts and other healthcare professionals from around the world but don’t take our word for it. Joanna Tokarska, a Physiotherapist from the National Chamber of Physiotherapists, Poland, reviews our LGMD European Masterclass which took part back in April of this year...

 
Read More
‌
‌
Uncategorized HandsSunset 002

Duchenne Mother Fights for Social Security Benefits for Individuals with Duchenne Muscular Dystrophy

Tiffany Cook, mother to a son with Duchenne muscular dystrophy and Senior Director of CureDuchenne Cares, has faced the financial burden of Duchenne for 15 years, and decided enough was enough.

In 2018, Tiffany, filed an application to add Duchenne to the Social Security Administration Compassionate Allowance List (CAL). Three years later, her application was just approved...

 
Read More
‌
‌
Uncategorized Science Will Win

Science Will Win Podcast

The first episode of Science Will Win a new podcast from Pfizer is out now...

 
Read More
‌
‌
Uncategorized Speak Foundation

Multi-language Subtitles added to The Speak Foundations 2021 International Limb Girdle Muscular Dystrophy Conference

The Speak Foundation (the first patient-led organisation for muscular dystrophy) is excited to announce that YouTube has now enabled subtitles for all of their 2021 International Limb Girdle Muscular Dystrophy Conference programming...

 
Read More
‌
‌

Upcoming events

Below is a list of upcoming NMD/rare disease events. If you would like to advertise your event in the TREAT-NMD newsletter please complete the online form, or contact TREAT-NMD directly.

 
Read More
‌
‌
Uncategorized DMD Early Diagnosis Promo Image

New Education Event: Duchenne Muscular Dystrophy Early Diagnosis Seminar

TREAT-NMD is launching a new education initiative in Duchenne Muscular Dystrophy. The first TREAT-NMD Duchenne Muscular Dystrophy Early Diagnosis Seminar will take place in Spring 2022 (date TBC).  This educational event will explore how to identify the signs of Duchenne Muscular Dystrophy...

 
Read More
‌
‌
Uncategorized Masterclass Image

Congenital Myopathies Expert Masterclass, 2022

Whilst the programme for the new Congenital Myopathies Expert Masterclass is being finalised, TREAT-NMD can reveal that this event will be taking place online to European audience on Wednesday 23rd & Thursday 24th February 2022...  

 
Read More
‌
‌
Uncategorized EPNS 2022

Registration Open for the EPNS Congress

Registration is now open for the 14th EPNS Congress.  The congress will take place on 28 April – 2 May 2022...

 
Read More
‌
‌
Uncategorized Winterschool Logo

Results of Applications Announced for EURORDIS Winter School

EURORDIS has created training to expand the understanding of how pre-clinical research translates into real benefits for rare disease patients aimed at patient representatives...

 
Read More
‌
‌
Uncategorized Stock Image For Masterclass

1st International Conference on Rare Diseases and Paediatric Research

The First International Conference on Rare Diseases and Paediatric Research will take place virtually from the 18th to the 19th of November...

 
Read More
‌
‌
Uncategorized Duchenne Patient Academy

Applications open for Duchenne Patient Academy 2021

The Duchenne Data Foundation, in collaboration with the World Duchenne Organization, is launching the 2021 edition of the Duchenne Patient Academy (DPA). In this intensive training session, patient advocates receive training and updates to build a strong base for current and future global advocacy...

 
Read More
‌
Share this on Twitter
You have received this email because you have subscribed to TREAT-NMD as . If you no longer wish to receive emails please unsubscribe
webversion - unsubscribe - update profile
© 2023 TREAT-NMD, All rights reserved